Journal Articles Autoimmunity Reviews Year : 2022

An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management

Fichier principal
Vignette du fichier
S1568997221002950.pdf (409.73 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03504767 , version 1 (08-01-2024)

Licence

Identifiers

Cite

Paul Decker, Thomas Moulinet, F. Pontille, M. Cravat, Marcelo de Carvalho-Bittencourt, et al.. An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management. Autoimmunity Reviews, 2022, 21 (3), pp.103013. ⟨10.1016/j.autrev.2021.103013⟩. ⟨hal-03504767⟩
100 View
80 Download

Altmetric

Share

More